Cargando…
Cellular Immunity—The Key to Long-Term Protection in Individuals Recovered from SARS-CoV-2 and after Vaccination
Previous clinical and epidemiological studies have shown that over time antibody titers decrease, and they do not provide long-term mucosa protection against SARS-CoV-2 infection. Additionally, the increase in breakthrough infections that occur more frequently in the vaccinated than in the study par...
Autores principales: | Primorac, Dragan, Brlek, Petar, Matišić, Vid, Molnar, Vilim, Vrdoljak, Kristijan, Zadro, Renata, Parčina, Marijo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8953558/ https://www.ncbi.nlm.nih.gov/pubmed/35335076 http://dx.doi.org/10.3390/vaccines10030442 |
Ejemplares similares
-
Adaptive Immune Responses and Immunity to SARS-CoV-2
por: Primorac, Dragan, et al.
Publicado: (2022) -
Importance of Cellular Immunity and IFN-γ Concentration in Preventing SARS-CoV-2 Infection and Reinfection: A Cohort Study
por: Primorac, Dragan, et al.
Publicado: (2023) -
Mesenchymal Stem Cell Mechanisms of Action and Clinical Effects in Osteoarthritis: A Narrative Review
por: Molnar, Vilim, et al.
Publicado: (2022) -
Population Pharmacogenomics in Croatia: Evaluating the PGx Allele Frequency and the Impact of Treatment Efficiency
por: Matišić, Vid, et al.
Publicado: (2023) -
Experience with comprehensive pharmacogenomic multi-gene panel in clinical practice: a retrospective single-center study
por: Matišić, Vid, et al.
Publicado: (2022)